Senti Biosciences Statistics Share Statistics Senti Biosciences has 26.08M
shares outstanding. The number of shares has increased by 469.58%
in one year.
Shares Outstanding 26.08M Shares Change (YoY) 469.58% Shares Change (QoQ) 0.37% Owned by Institutions (%) 2.53% Shares Floating 7.99M Failed to Deliver (FTD) Shares 358 FTD / Avg. Volume 0.12%
Short Selling Information The latest short interest is 655.2K, so 2.51% of the outstanding
shares have been sold short.
Short Interest 655.2K Short % of Shares Out 2.51% Short % of Float 2.53% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.31 and the forward
PE ratio is -0.74.
Senti Biosciences's PEG ratio is
0.01.
PE Ratio -0.31 Forward PE -0.74 PS Ratio 0 Forward PS 7.9 PB Ratio 0.63 P/FCF Ratio -0.39 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Senti Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.49,
with a Debt / Equity ratio of 1.31.
Current Ratio 4.49 Quick Ratio 4.49 Debt / Equity 1.31 Debt / EBITDA -0.72 Debt / FCF -0.81 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.55M Employee Count 34 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -15.17% in the
last 52 weeks. The beta is 2.07, so Senti Biosciences's
price volatility has been higher than the market average.
Beta 2.07 52-Week Price Change -15.17% 50-Day Moving Average 2.3 200-Day Moving Average 3.29 Relative Strength Index (RSI) 30.05 Average Volume (20 Days) 303,958
Income Statement
Revenue n/a Gross Profit n/a Operating Income -61.04M Net Income -52.79M EBITDA -46.94M EBIT -52.79M Earnings Per Share (EPS) -11.49
Full Income Statement Balance Sheet The company has 48.28M in cash and 33.64M in
debt, giving a net cash position of 14.64M.
Cash & Cash Equivalents 48.28M Total Debt 33.64M Net Cash 14.64M Retained Earnings -297.13M Total Assets 68.54M Working Capital 22.53M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -41.4M
and capital expenditures -26K, giving a free cash flow of -41.42M.
Operating Cash Flow -41.4M Capital Expenditures -26K Free Cash Flow -41.42M FCF Per Share -9.01
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields SNTI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for SNTI is $8.5,
which is 462.9% higher than the current price. The consensus rating is "Buy".
Price Target $8.5 Price Target Difference 462.9% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 18, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date Jul 18, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -7.86 Piotroski F-Score 3
